Are Pharmacy Closures the Tonic Behind Deshengtang’s Profits?
The druggist, which has applied for a Hong Kong IPO, reported a tiny profit in the first nine months of last year, possibly due to savings after large-scale store closuresKey…
Catching Listing Chill, Dingdang Health Slashes Hong Kong IPO
China’s third largest digital retail pharmacy has been approved for a Hong Kong IPO, but cut the size by 90% from an earlier target Key Takeaways: Dingdang Health has passed…
Online Medical Educator Huayiwang Seeks Growth Booster from IPO
The educational platform operator slipped into the red in the first five months of this year as it faces growing competition Key Takeaways: Hong Kong IPO candidate Huayiwang Technology recorded…
ClouDr Suffers Chronic Losses but Still Set for High-Value Health IPO
Online medical services provider ClouDr is about to list on the Hong Kong Stock Exchange. Its losses over three years amount to 7.6 billion yuan, but its IPO valuation is…
Yuanxin Tempts Investors With One-Stop Medical Formula in Hong Kong IPO
The internet healthcare company filed its listing application to the Hong Kong Stock Exchange last week, trumpeting its comprehensive approach to medical services Key takeaways: Yuanxin Technology has filed for…
After Roller Coaster Year, Yidu Stock Settles Down Post-IPO
Big-data healthcare services provider’s operating loss widened in its latest reporting period as revenue grew 62% Key Takeaways: Yidu’s revenue rose 62% in the six months through SeptemberCompany’s health management…
Online Drug Supplier 111 Finds Tonic in B2B Focus
Company adds two fulfillment centers, inks deal with cancer drug maker BeiGene, in drive to consolidate its place as premier B2B specialist Key takeaways 111 Inc.’s aggressive pursuit of partnerships…
